Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 11, Issue 9
|
pp. 2724–2734
Rosiglitazone has a neutral effect on the risk of dementia in type 2 diabetes patients
Back to article
Figure 1
−
100%
+
Figure 1.
Flowchart for the procedures in selecting a propensity score matched cohort of rosiglitazone ever users and never users.
